CNP-103

· COUR Pharmaceutical Development Company, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CNP-103, covering 2026-03-10 to 2026-03-10. Get the full timeline:

Most recent: Clinical Trial Update: CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D) [Phase 1, Phase 2]

See pricing